Medical - Instruments & Supplies
Build Your Comparison
Side-by-side financial analysisStock Comparison
NYXH vs AVAV
Revenue, margins, valuation, and 5-year total return — side by side.
Aerospace & Defense
NYXH vs AVAV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Aerospace & Defense |
| Market Cap | $52M | $8.52B |
| Revenue (TTM) | $16M | $1.61B |
| Net Income (TTM) | $-86M | $-224M |
| Gross Margin | 48.3% | 21.8% |
| Operating Margin | -5.3% | -8.3% |
| Forward P/E | — | 59.2x |
| Total Debt | $42M | $64M |
| Cash & Equiv. | $30M | $41M |
NYXH vs AVAV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | Jun 26 | Return |
|---|---|---|---|
| Nyxoah S.A. (NYXH) | 100 | 5.8 | -94.2% |
| AeroVironment, Inc. (AVAV) | 100 | 154.6 | +54.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NYXH vs AVAV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NYXH is the clearest fit if your priority is growth exposure.
- Rev growth 121.6%, EPS growth -30.9%, 3Y rev CAGR 48.1%
- 121.6% revenue growth vs AVAV's 14.5%
AVAV carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 1.90
- 445.9% 10Y total return vs NYXH's -94.2%
- Lower volatility, beta 1.90, Low D/E 7.3%, current ratio 3.52x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 121.6% revenue growth vs AVAV's 14.5% | |
| Quality / Margins | -13.9% margin vs NYXH's -5.3% | |
| Stability / Safety | Beta 1.90 vs NYXH's 2.10, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -10.3% vs NYXH's -81.6% | |
| Efficiency (ROA) | -5.0% ROA vs NYXH's -80.8%, ROIC 3.6% vs -76.4% |
NYXH vs AVAV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NYXH vs AVAV — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — NYXH and AVAV each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVAV is the larger business by revenue, generating $1.6B annually — 98.7x NYXH's $16M. Profitability is closely matched — net margins range from -13.9% (AVAV) to -5.3% (NYXH). On growth, NYXH holds the edge at +5.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $16M | $1.6B |
| EBITDAEarnings before interest/tax | -$81M | $82M |
| Net IncomeAfter-tax profit | -$86M | -$224M |
| Free Cash FlowCash after capex | -$73M | -$183M |
| Gross MarginGross profit ÷ Revenue | +48.3% | +21.8% |
| Operating MarginEBIT ÷ Revenue | -5.3% | -8.3% |
| Net MarginNet income ÷ Revenue | -5.3% | -13.9% |
| FCF MarginFCF ÷ Revenue | -4.5% | -11.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.9% | +143.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.3% | -51.5% |
Valuation Metrics
NYXH leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $52M | $8.5B |
| Enterprise ValueMkt cap + debt − cash | $66M | $8.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.51x | 110.05x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 59.24x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 104.43x |
| Price / SalesMarket cap ÷ Revenue | 4.48x | 10.38x |
| Price / BookPrice ÷ Book value/share | 0.93x | 5.42x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
AVAV leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
AVAV delivers a -6.4% return on equity — every $100 of shareholder capital generates $-6 in annual profit, vs $-164 for NYXH. AVAV carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to NYXH's 0.86x. On the Piotroski fundamental quality scale (0–9), AVAV scores 3/9 vs NYXH's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -164.4% | -6.4% |
| ROA (TTM)Return on assets | -80.8% | -5.0% |
| ROICReturn on invested capital | -76.4% | +3.6% |
| ROCEReturn on capital employed | -80.4% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.86x | 0.07x |
| Net DebtTotal debt minus cash | $12M | $23M |
| Cash & Equiv.Liquid assets | $30M | $41M |
| Total DebtShort + long-term debt | $42M | $64M |
| Interest CoverageEBIT ÷ Interest expense | -32.73x | -5.99x |
Total Returns (Dividends Reinvested)
AVAV leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AVAV five years ago would be worth $15,065 today (with dividends reinvested), compared to $515 for NYXH. Over the past 12 months, AVAV leads with a -10.3% total return vs NYXH's -81.6%. The 3-year compound annual growth rate (CAGR) favors AVAV at 20.8% vs NYXH's -44.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -69.1% | -33.4% |
| 1-Year ReturnPast 12 months | -81.6% | -10.3% |
| 3-Year ReturnCumulative with dividends | -82.4% | +76.1% |
| 5-Year ReturnCumulative with dividends | -94.9% | +50.6% |
| 10-Year ReturnCumulative with dividends | -94.2% | +445.9% |
| CAGR (3Y)Annualised 3-year return | -44.0% | +20.8% |
Risk & Volatility
AVAV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AVAV is the less volatile stock with a 1.90 beta — it tends to amplify market swings less than NYXH's 2.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AVAV currently trades 40.8% from its 52-week high vs NYXH's 16.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.10x | 1.90x |
| 52-Week HighHighest price in past year | $8.59 | $417.86 |
| 52-Week LowLowest price in past year | $1.26 | $156.29 |
| % of 52W HighCurrent price vs 52-week peak | +16.2% | +40.8% |
| RSI (14)Momentum oscillator 0–100 | 25.8 | 49.4 |
| Avg Volume (50D)Average daily shares traded | 189K | 1.1M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates NYXH as "Buy" and AVAV as "Buy". Consensus price targets imply 331.7% upside for NYXH (target: $6) vs 71.3% for AVAV (target: $292).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $6.00 | $292.20 |
| # AnalystsCovering analysts | 5 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
AVAV leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). NYXH leads in 1 (Valuation Metrics). 1 tied.
NYXH vs AVAV: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is NYXH or AVAV a better buy right now?
For growth investors, Nyxoah S.
A. (NYXH) is the stronger pick with 121. 6% revenue growth year-over-year, versus 14. 5% for AeroVironment, Inc. (AVAV). AeroVironment, Inc. (AVAV) offers the better valuation at 110. 1x trailing P/E (59. 2x forward), making it the more compelling value choice. Analysts rate Nyxoah S. A. (NYXH) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NYXH or AVAV?
Over the past 5 years, AeroVironment, Inc.
(AVAV) delivered a total return of +50. 6%, compared to -94. 9% for Nyxoah S. A. (NYXH). Over 10 years, the gap is even starker: AVAV returned +445. 9% versus NYXH's -94. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NYXH or AVAV?
By beta (market sensitivity over 5 years), AeroVironment, Inc.
(AVAV) is the lower-risk stock at 1. 90β versus Nyxoah S. A. 's 2. 10β — meaning NYXH is approximately 11% more volatile than AVAV relative to the S&P 500. On balance sheet safety, AeroVironment, Inc. (AVAV) carries a lower debt/equity ratio of 7% versus 86% for Nyxoah S. A. — giving it more financial flexibility in a downturn.
04Which is growing faster — NYXH or AVAV?
By revenue growth (latest reported year), Nyxoah S.
A. (NYXH) is pulling ahead at 121. 6% versus 14. 5% for AeroVironment, Inc. (AVAV). On earnings-per-share growth, the picture is similar: AeroVironment, Inc. grew EPS -28. 9% year-over-year, compared to -30. 9% for Nyxoah S. A.. Over a 3-year CAGR, NYXH leads at 48. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NYXH or AVAV?
AeroVironment, Inc.
(AVAV) is the more profitable company, earning 5. 3% net margin versus -899. 1% for Nyxoah S. A. — meaning it keeps 5. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVAV leads at 5. 0% versus -827. 8% for NYXH. At the gross margin level — before operating expenses — NYXH leads at 63. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is NYXH or AVAV more undervalued right now?
Analyst consensus price targets imply the most upside for NYXH: 331.
7% to $6. 00.
07Which pays a better dividend — NYXH or AVAV?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is NYXH or AVAV better for a retirement portfolio?
For long-horizon retirement investors, AeroVironment, Inc.
(AVAV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+445. 9% 10Y return). Nyxoah S. A. (NYXH) carries a higher beta of 2. 10 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AVAV: +445. 9%, NYXH: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between NYXH and AVAV?
These companies operate in different sectors (NYXH (Healthcare) and AVAV (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NYXH is a small-cap high-growth stock; AVAV is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.